Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Biomedicines ; 12(6)2024 May 28.
Article in English | MEDLINE | ID: mdl-38927407

ABSTRACT

Fermented prebiotic and probiotic products with kefir are very important to slow down and prevent the growth of tumors and to treat cancer by stimulating the immune response against tumor cells. Cyclophosphamide (CPx) is widely preferred in cancer treatment but its effectiveness in high doses is restricted because of its side effects. The aim of this study was to investigate the protective effects of kefir against CPx-induced heart and liver toxicity. In an experiment, 42 Wistar albino rats were divided into six treatment groups: the control (Group 1), the group receiving 150 mg/kg CPx (Group 2), the groups receiving 5 and 10 mg/kg kefir (Groups 3 and 4) and the groups receiving 5 and 10 mg/kg kefir + CPx (Group 5 and 6). Fermented kefirs obtained on different days by traditional methods were mixed and given by gavage for 12 days, while a single dose of CPx was administered intraperitoneally (i.p.) on the 12th day of the experiment. It was observed that alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), creatinine kinase-MB (CK-MB), ischemia modified albumin (IMA) and Troponin I values, which indicate oxidative stress, increased in the CPx-administered group, and this level approached that of the control in the CPx + kefir groups. Likewise, as a result of the kefir, the rats' CPx-induced histopathological symptoms were reduced, and their heart and liver tissue were significantly improved. In conclusion, it was observed that kefir had a cytoprotective effect against CPx-induced oxidative stress, hepatotoxicity and cardiotoxicity, bringing their biochemical parameters closer to those of the control by suppressing oxidative stress and reducing tissue damage.

2.
Environ Toxicol Pharmacol ; 102: 104218, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37451528

ABSTRACT

Cadmium chloride (Cd) and sodium arsenite (As) are two prominent examples of non-biodegradable substances that accumulate in ecosystems, pose a serious risk to human health and are not biodegradable. Although the toxicity caused by individual use of Cd and As is known, the toxicity of combined use (Cd+As) to mammals is poorly understood. The present study aims to investigate the hepatoprotective effect of curcumin (CUR), a naturally occurring bioactive component isolated from the root stem of Curcuma longa Linn., in preventing liver damage caused by a Cd+As mixture. A group of 30 Sprague-Dawley rats were subjected to intraperitoneal administration of Cd+As (0.44 mg/kg+5.55 mg/kg i.p.) and CUR (100 or 200 mg/kg) for a period of 14 days. The experimental results showed that the animals treated with Cd+As exhibited changes in liver biochemical parameters, inflammation and oxidative stress at the end of the experiment. Administration of CUR significantly reduced inflammation, oxidative stress and lipid peroxidation in the Cd+As plus CUR groups compared to the Cd+As group. Furthermore, histological examination of the liver tissue showed that administration of CUR had led to a significant reduction in the liver damage observed in the Cd+As group. The present study provides scientific evidence for the protective effects of CUR against lipid peroxidation, inflammation, oxidative stress and liver damage induced by Cd+As in the liver of rats. The results of our in vivo experiments were confirmed by those of our molecular modelling studies, which showed that CUR can enhance the diminished antioxidant capacity caused by Cd+As.


Subject(s)
Arsenic , Curcumin , Liver Diseases , Humans , Rats , Animals , Cadmium/metabolism , Curcumin/pharmacology , Arsenic/toxicity , Arsenic/metabolism , NF-kappa B/metabolism , Interleukin-1beta/metabolism , Ecosystem , Rats, Sprague-Dawley , Antioxidants/pharmacology , Antioxidants/metabolism , Oxidative Stress , Liver , Liver Diseases/metabolism , Inflammation/metabolism , Mammals
3.
Indian J Pathol Microbiol ; 65(4): 750-754, 2022.
Article in English | MEDLINE | ID: mdl-36308175

ABSTRACT

Aim: The aim of our study is to analyze the staining models for VEGF, p16, and p53, as well as to understand the biology of inverted papilloma caused by smoking. Materials and Methods: Thirty-one cases, diagnosed with sinonasal inverted papilloma between 2015 and 2019, were included. Demographic data such as age and gender, admission symptoms of the patients, and anatomical location, stage, surgical technique, and recurrence information were obtained from clinical follow-up files. Immunohistochemical staining for p16, VEGF, and p53 were performed on patient materials. Results: In our study, the female to male ratio was 9.33 with an average age of 53.137 ± 13.96 years. Of the patients, 17 were nonsmokers and 14 were smokers. No significant relationship was found between smoking status and relapse and dysplasia. In contrast, a significant relationship between the Krouse stage and dysplasia (P = 0.005) was observed. A similar significant relationship was observed between p16 immunohistochemical expression and dysplasia (P = 0.030). On the other hand, VEGF and p53 immunohistochemical expressions were not significantly related with dysplasia and recurrence. Conclusions: Inverted papillomas are benign tumors that clinically give symptoms similar to nasal polyps. However, recurrence and malignant transformation potential exist and the factors causing this risk are not clearly identified. In our study, no malignant transformation was observed in patients who were admitted to our hospital.


Subject(s)
Nose Neoplasms , Papilloma, Inverted , Humans , Male , Female , Adult , Middle Aged , Aged , Papilloma, Inverted/pathology , Tumor Suppressor Protein p53 , Vascular Endothelial Growth Factor A , Prognosis , Neoplasm Recurrence, Local , Nose Neoplasms/diagnosis , Nose Neoplasms/pathology , Cell Transformation, Neoplastic , Smoking/adverse effects , Retrospective Studies
4.
Life Sci ; 307: 120864, 2022 Oct 15.
Article in English | MEDLINE | ID: mdl-35940215

ABSTRACT

INTRODUCTION: This study aims to investigate whether boric acid (BA) can protect rats from acrylamide (AA)-induced acute liver injury. MATERIALS AND METHODS: AA was used to induce acute liver injury. Thirty rats were divided into five group including Group 1 (saline), Group 2 (AA), Group 3 (20 mg/kg BA), Group 4 (10 mg/kg BA+AA) and Group 5 (20 mg/kg BA+AA). Their blood and liver were harvested to be kept for analysis. Liver function enzyme activities were performed by spectrophotometric method. Catalase (CAT), superoxide dismutase (SOD) activity, and malondialdehyde levels were determined by colorimetric method. The in-silico studies were performed using the "blind docking" method. RESULTS: Administration AA to rats, biochemical parameters, liver histology, and expression levels of apoptotic markers were negatively affected. However, after the administration of BA, the altered biochemical parameters, liver histology, and expression levels of apoptotic markers were reversed. Moreover, the mechanisms of AA-induced deterioration in the levels of SOD, CAT, and Nrf2-Keap-1 and the mechanisms of the protective effect of BA against these deteriorations were explained by in silico studies. CONCLUSION: Thus, the present study could explain the interactions between AA and thiol-containing amino acid residues of Keap-1, the effect of BA on these interactions, and the biochemical toxicity caused by the AA. In this sense, this work is the first of its kind in the literature. Based on the biochemical, histopathological, and in silico results, it can be suggested that BA has the potential to be used as a protective agent against AA-induced liver injury.


Subject(s)
Acrylamide , NF-E2-Related Factor 2 , Animals , Rats , Acrylamide/toxicity , Amino Acids/metabolism , Antioxidants/metabolism , Antioxidants/pharmacology , bcl-2-Associated X Protein/metabolism , Boric Acids , Catalase/metabolism , Liver/metabolism , Malondialdehyde/metabolism , NF-E2-Related Factor 2/metabolism , Oxidative Stress , Protective Agents/metabolism , Protective Agents/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction , Sulfhydryl Compounds/metabolism , Sulfhydryl Compounds/pharmacology , Superoxide Dismutase/metabolism
5.
Toxicol Appl Pharmacol ; 411: 115386, 2021 01 15.
Article in English | MEDLINE | ID: mdl-33383042

ABSTRACT

This study aims to investigate whether Escin (ES) can protect against Cyclophosphamide (CPM)-induced cardiac damage. The experimental rats were categorized as Control, CPM (200 mg/kg), ES (10 mg/kg), and CPM + ES Groups, each having 6 members. Their heart tissues were stained with Hematoxylin and Eosin and the structural changes were investigated under the light microscope. The biochemical markers of ischemia modified albumin (IMA), creatine kinase (CK-MB), antioxidant activity indicators Catalase (CAT), and superoxide dismutase (SOD) activities were measured using blood samples. Besides, the effects of CPM, ES, and CPM + ES upon CAT and SOD activities were shown via molecular docking studies. In the Single-Dose CPM group, CK-MB and IMA levels significantly increased while SOD and CAT levels significantly decreased. However, the heart tissues were damaged. CK-MB and IMA levels significantly decreased in CP+ ES Group. On the other hand, SOD, and CAT levels significantly increased and reduced the damage remarkably. Our findings showed that ES treatment successfully reduced the toxic effects upon the rats. The conclusion is that ES treatment can help protect the heart tissue against CPM-induced toxicity. Both in-vivo results and molecular modeling studies showed that the negative effects of CPM upon SOD activity were bigger than that of CAT.


Subject(s)
Antioxidants/pharmacology , Cyclophosphamide , Escin/pharmacology , Heart Diseases/prevention & control , Molecular Docking Simulation , Myocytes, Cardiac/drug effects , Oxidative Stress/drug effects , Animals , Antioxidants/chemistry , Biomarkers/blood , Cardiotoxicity , Catalase/blood , Catalase/chemistry , Creatine Kinase, MB Form/blood , Disease Models, Animal , Escin/chemistry , Heart Diseases/blood , Heart Diseases/chemically induced , Heart Diseases/pathology , Male , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Protein Conformation , Rats, Sprague-Dawley , Serum Albumin, Human , Structure-Activity Relationship , Superoxide Dismutase/blood , Superoxide Dismutase/chemistry
6.
Int J Pediatr Otorhinolaryngol ; 84: 81-7, 2016 May.
Article in English | MEDLINE | ID: mdl-27063758

ABSTRACT

OBJECTIVES: The effect of cinnamaldehyde on the treatment of allergic rhinitis (AR) was investigated in rat model. METHODS: Twenty-eight female Wistar albino rats were randomly divided into four groups: Group 1 (control) (C), Group 2 (AR with no treatment) (AR+NoTr), Group 3 (AR+Azelastine HCl) (AR+Aze), and Group 4 (AR+cinnamaldehyde) (AR+Cin). At day 21, AR+Aze rats were given an Azelastine HCl drop, and AR+Cin rats were given cinnamaldehyde intranasally. In all groups, allergic symptoms histopathological results were evaluated. RESULTS: The AR+NoTr group showed the worst allergic symptoms, cilia loss and greater inflammation. In the AR+Aze and AR+Cin groups, allergic symptom scores were higher than those in the control group. However, between AR+Aze and AR+Cin groups, there were no significant differences in the allergic symptom scores Histopathological analysis revealed vascular congestion and an increase in goblet cell numbers in the AR+Cin group. However, AR+Cin rat nasal mucosa had less plasma cell infiltration compared with the AR+NoTr group. In rats from the AR+Aze group, analysis of the nasal mucosa revealed less eosinophil infiltration than that seen in the AR+NoTr group. A lower score for mast cell (MC) infiltration was observed in the nasal mucosa of rats treated with Azelastine HCl compared with cinnamaldehyde. CONCLUSIONS: In this study we observed that both Azelastine HCl and cinnamaldehyde reduced allergic symptoms in an AR rat model. Cinnamaldehyde decreased vascular congestion as well as plasma cell, eosinophil, and inflammatory cell infiltration into the lamina propria.


Subject(s)
Acrolein/analogs & derivatives , Anti-Allergic Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Phthalazines/therapeutic use , Rhinitis, Allergic/drug therapy , Acrolein/therapeutic use , Administration, Intranasal , Animals , Drug Therapy, Combination , Female , Random Allocation , Rats , Rats, Wistar , Treatment Outcome
7.
Eur Arch Otorhinolaryngol ; 272(1): 9-13, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24627077

ABSTRACT

Analysis of acute cellular changes seen in nasal mucosa of Wistar-Albino rats exposed to different doses of oleoresin capsicum for various time periods by means of scanning electron microscopy. Thirty-five Wistar-Albino rats were divided into five groups of seven rats each. 6-gram oleoresin capsicum per second was sprayed into cages of the groups except group 1. Spray times and duration of exposure to pepper gasses were different for each group. Thirty minutes after the exposure, the animals were killed and specimens from their nasal mucosas were harvested and examined under scanning electron microscope. Mucosal damage was scored from 0-4 points. Mean values of nasal mucosa damage scores of the groups were calculated and compared statistically. Average damage scores of the groups exposed to identical doses of oleoresin capsicum for various exposure times were compared and a statistically significant difference was seen between Groups 2 and 3 (p < 0.05), however the difference between Groups 4 and 5 was insignificant (p > 0.05). Average damage scores of the groups exposed to various doses for identical exposure times were compared, and statistically significant differences were observed between Groups 2 and 4 and also Groups 3 and 5 (p < 0.05). Outcomes of our study have demonstrated that pepper gas exerts destructive changes on rat nasal mucosa. The extent of these destructive changes increases with the prolonged exposure to higher doses. Besides, exposure time also stands out as an influential factor on the extent of the destructive changes.


Subject(s)
Microscopy, Electron, Scanning , Nasal Mucosa/drug effects , Nasal Mucosa/ultrastructure , Plant Extracts/pharmacology , Animals , Dose-Response Relationship, Drug , Male , Rats , Rats, Wistar
8.
Dermatol Surg ; 40(12): 1402-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25350124

ABSTRACT

BACKGROUND: The accuracy of the diagnosis of skin lesions has an important effect in outcomes in treatment selection and prioritization of the treatment. OBJECTIVE: To assess the effect of preoperative evaluations by dermatologists on the diagnostic accuracy of plastic surgeons. MATERIALS AND METHODS: A retrospective analysis was performed on 1,146 biopsies that were excised by plastic surgeons in our secondary State Hospital. The histopathologic diagnoses were divided into 2 groups according to the preoperative dermatological evaluation, with Group 1 being the lesions that were evaluated by a dermatologist before excision and Group 2 being the lesions that were not evaluated by a dermatologist before excision. The sensitivity and positive predictive values (PPVs) were calculated and compared between the 2 groups using Fisher exact test. RESULTS: The PPVs of the malignant lesions of Groups 1 and 2 were 53.8% and 25.0%, respectively (p = .001). When Group 1 was contrasted with Group 2, the PPVs for the premalignant lesions were 71.4% and 46.8%, respectively (p = .015). The PPV for the benign lesions was 86.3% in Group 1 and 72.6% in Group 2 (p < .001). CONCLUSION: This study demonstrated that the diagnostic accuracy of plastic surgeons was affected positively by preoperative evaluations by a dermatologist.


Subject(s)
Dermatology , Skin Diseases/diagnosis , Adolescent , Adult , Aged , Biopsy , Child , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Practice Patterns, Physicians' , Predictive Value of Tests , Preoperative Care , Retrospective Studies , Sensitivity and Specificity , Skin Diseases/pathology , Skin Diseases/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...